Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 439
Selected: 0
NCT IDTitle
NCT04805060A Study to Evaluate the Tolerance and Pharmacokinetics of TQB2858 Injection in Subjects With Terminal Malignant Tumors
NCT04056754Study of Abiraterone Acetate in Subjects With Metastatic Castration Resistant Prostate Cancer
NCT03456466Study of TQB2303 in Patients With Aggressive CD20 Positive Non-Hodgkin's Lymphoma
NCT03778138Study of Anlotinib Combined With Pemetrexed in Patients With Advanced Nonsquamous NSCLC
NCT05576480SCRT Sequential Penpulimab in Combination With CAPEOX in the Neoadjuvant Treatment of MSS Locally Advanced Rectal Cancer
NCT06552520To Evaluate the Phase III Clinical Trial of TQH2722 Injection in the Treatment of Moderate to Severe Atopic Dermatitis
NCT05640804A Bioequivalence Study of Dasatinib Tablet
NCT06672263A Clinical Trial to Evaluate the Safety and Tolerability of TQB3911 Tablets in Patients With BCR::ABL Fusion Gene Positive Leukemia
NCT06452706The Clinical Trial of TQB2102 for Injection Against Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer
NCT07037238An Open-Label, Single-Arm Exploratory Clinical Study of Everolimus for the Treatment of Vascular Malformations
NCT07252908A Phase II Clinical Trial on the Efficacy and Safety of TQC3721 Inhalation Powder
NCT03457844A Study of Anlotinib in Patients With Gastroenteropancreatic Neuroendocrine Tumor G3
NCT05975645A Clinical Study of TQB2618 Injection Combined With Penpulimab Injection and Anlotinib Hydrochloride Capsules for First-line Treatment of Advanced Hepatocellular Carcinoma (HCC).
NCT04278820A Study of TQA3526 in the Treatment of Primary Biliary Cirrhosis (PBC)
NCT05494060XELOX Combined With Anlotinib and Penpulimab vs XELOX as Adjuvant Therapy in ctDNA Positive Gastric and Esophagogastric Junction Adenocarcinoma
NCT03890068Anlotinib Maintenance Treatment for Advanced Soft Tissue Sarcoma
NCT04398940A Study of TQ-B3139 Capsules in Subjects With MET-Altered Advanced Non-small Cell Lung Cancer
NCT05013697TQB2450 Solution for Injection (TQB2450)+Paclitaxel+Cisplatin ± Anlotinib in the Treatment of Esophageal Cancer.
NCT07260708Clinical Trial of TQB2922 Injection (Subcutaneous Injection) in Patients With Advanced Cancers
NCT05292196A Phase II Clinical Trial of TQC3721 Suspension for Inhalation
NCT06188624Clinical Trial of TQB2922 for Injection in Patients With Advanced Cancers
NCT06415903A Clinical Trial of TQB3117 Tablets in Patients With Advanced Malignant Cancer
NCT06202261A Study of TQB2930 for Injection Monotherapy or Combination Therapy in Patients With Recurrent/Metastatic Breast Cancer
NCT07110194Phase I Clinical Trial of TQB2825 Subcutaneous Injection in CD20-positive Hematological Malignancies
NCT01846650A Bioequivalence Study of Capecitabine Tablets
NCT07113925A Clinical Trial Evaluating TQB2101 in Subjects With Advanced Hematologic Malignancies
NCT04061109Safety, Efficacy Evaluation of Recombinant Coagulation Factor VIII Injection in Subjects With Hemophilia A.
NCT06943677A Clinical Trial on the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of TQB3019 Capsule in Subjects With Advanced Malignant Tumors
NCT03983928Study of TQB2450 Combined With Anlotinib in the Treatment of Mutation Positive Lung Cancer
NCT04956328Study of Obeticholic Acid(OCA) Combination With Ursodeoxycholic Acid (UDCA) in Patients With Primay Biliary Cirrhosis (PBC)
NCT07043725A Clinical Study of Neoadjuvant Treatment With TQB2102 for Injection for Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer
NCT04944043A Study of TQ05105 in Patients With Chronic Graft Versus Host Disease
NCT06251947Efbemalenograstim Alfa Injection for Ovarian or Cervical Cancer Receiving Chemotherapy Regimen
NCT05987358A Clinical Study of TQB3454 Tablets in the Treatment of Advanced Biliary Carcinoma.
NCT05493995A Study of Penpulimab and Anlotinib Plus Nab-paclitaxel and Gemcitabine for Metastatic Pancreatic Cancer.
NCT04481607A Study to Evaluate the Tolerance, Efficacy and Pharmacokinetics of TQB3454 Tablets
NCT05830500Study of Anlotinib in Patients With Advanced Medullary Thyroid Carcinoma
NCT05154630Study on Tolerability and Pharmacokinetics of TQB2858 Injection in Subjects With Advanced Malignant Tumors
NCT06211751A Clinical Trial of TQB3909 Tablets Combined With TQB3702 Tablets in Patients With Hematologic Malignancy
NCT05068921A Clinical Trial to Evaluate Tolerability and Pharmacokinetics of TQB2858 Injection in Subjects With Advanced Malignancy
NCT06139367A Clinical Trial of TQB3454 Tablets in Healthy Adult Subjects
NCT04619563A Trial of Anlotinib Combined With Docetaxel in EGFR Mutations Advanced Non Small Cell Lung Cancer Patients
NCT06431490A Study of TQB2102 for Injection in the Treatment of HER2-positive Biliary Tract Cancer
NCT04355520A Study of TQ-B3525 Tablets Combined With Fulvestrant Injection in Subjects With HR-positive, HER2-negative and PIK3CA Mutation Advanced Breast Cancer
NCT03855384Study of TQB2450 in Patients With Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck(R/M SCCHN)
NCT05193604A Clinical Trial to Evaluate Tolerability and Security of TQB2858 Injection in Subjects With Advanced Pancreatic Carcinoma
NCT04324879A Study of TQ-B3525 in the Treatment of Relapsed / Refractory Follicular Lymphoma (FL)
NCT05735496Clinical Trial of the TQB2102 Injection in Patients With Advanced Cancers
NCT06962267A Clinical Study on the First-line Treatment of Metastatic Pancreatic Cancer With TQB2916 Injection Combined With Gemcitabine Hydrochloride for Injection and Paclitaxel for Injection (Albumin-bound Type)
NCT02930317Evaluate Efficacy and Safety of Recombinant Factor VIII (rFVIII)Treatment of Severe or Moderately Severe Hemophilia A